Teams at Bicycle Therapeutics

Designs and executes in vitro and in vivo radiobiology studies to evaluate efficacy, mechanism of action, and radiobiological effects of Bicycle radioconjugates. Runs DNA damage, cell cycle, and cell death assays; characterizes tumour and tumour microenvironment responses; supports CRO/academic collaborations, analyzes data, documents results, and contributes to biomarker identification and scientific communications.